Patent · US Active

B cell maturation antigen (BCMA) binding proteins

US9273141B2 · kind B2 · utility

12Cited by
26References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 12, 2013
Grant dateMar 1, 2016
Priority date—
Expiry dateApr 4, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention concerns antigen binding proteins and fragments thereof which specifically bind B Cell Maturation Antigen (BCMA), particularly human BCMA (hBCMA) and which inhibit the binding of BAFF and APRIL to the BCMA receptor. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.